The Journal of Immunology · 2008 · 52 citations · 16 references
Veterinary MedicineImmunologyInfectious DiseasesImmunizationInflammationVaccinologyImmune Response To VaccinationInnate Immune ActivationInnate Immune ResponseInterferon ResponsesVaccinationViral VaccinesEosinophil-mediated InflammationEosinophil-mediated ResponsesRespiratory Syncytial Virus VaccinesTh1 Immune ResponseTh1 ResponsesTissue EosinophiliaVaccination Against Respiratory PathogensVaccinia Virus Vectors
Respiratory syncytial virus (RSV) infection of BALB/c mice previously immunized with a recombinant vaccinia virus (vacv) expressing the attachment (G) protein of RSV (vacvG) results in pulmonary eosinophilia, which mimics the response of formalin-inactivated RSV-vaccinated children, as well as increased weight loss, clinical illness, and enhanced pause (Penh). We show that RSV infection of eosinophil-deficient mice previously immunized with vacvG results in the development of increased weight loss, clinical illness, and Penh similar to that in wild-type controls. These measures of RSV vaccine-enhanced disease are dependent upon STAT4. Interestingly, neither IL-12 nor IL-23, the two most common STAT4-activating cytokines, proved necessary for the development of disease. We demonstrate that IFN-gamma, which is produced following STAT4 activation, contributes to clinical illness and increased Penh, but not weight loss. Our results have important implications for future RSV vaccine design, suggesting that enhancing a Th1 response may exacerbate disease.
16
Michiko Kobayashi, Lori Fitz, Michael P. Ryan et al. · The Journal of Experimental Medicine · 1989 · 2K citations · Full text
Stat6 Is Required for Mediating Responses to IL-4 and for the Development of Th2 Cells
Mark H. Kaplan, Ulrike Schindler, Stephen T. Smiley et al. · Immunity · 1996 · 1.6K citations · Full text